학술논문
Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial
Document Type
Article
Author
Source
In The Lancet Gastroenterology & Hepatology August 2023 8(8):735-747
Subject
Language
ISSN
2468-1253